Hangzhou AGS MedTech Co Ltd. Stock Analysis 688581.SS

Hangzhou AGS MedTech Co., Ltd. engages in the research, development, manufacture, and sale of equipment in minimally invasive diagnosis and treat. The company is headquartered in Hangzhou, Zhejiang and currently employs 807 full-time employees. The company went IPO on 2023-05-19. The firm's products are categorized by therapeutic use: hemostasis and closure devices, endoscopic mucosal resection (EMR)/endoscopic submucosal dissection (ESD) devices, biopsy devices, endoscopic retrograde cholangio pancreatography (ERCP) devices, and diagnostic and therapeutic instruments. The firm's main products include hemostatic clips, electric snares, endoscopic water delivery devices, disposable guidewires and others. The firm's main products are used in the field of digestive endoscopy. The firm operates in both domestic and overseas markets.